Gandara DR - Search Results

1

A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases.

Lara PN Jr, Stadler WM, Longmate J, Quinn DI, Wexler J, Van Loan M, Twardowski P, Gumerlock PH, Vogelzang NJ, Vokes EE, Lenz HJ, Doroshow JH, Gandara DR. Lara PN Jr, et al. Among authors: gandara dr. Clin Cancer Res. 2006 Mar 1;12(5):1556-63. doi: 10.1158/1078-0432.CCR-05-2074. Clin Cancer Res. 2006. PMID: 16533781 Clinical Trial.

2

Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen.

Gandara DR, Wold H, Perez EA, Deisseroth AB, Doroshow J, Meyers F, McWhirter K, Hannigan J, De Gregorio MW. Gandara DR, et al. J Natl Cancer Inst. 1989 May 10;81(10):790-4. doi: 10.1093/jnci/81.10.790. J Natl Cancer Inst. 1989. PMID: 2541260

3

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group.

Gandara DR, Crowley J, Livingston RB, Perez EA, Taylor CW, Weiss G, Neefe JR, Hutchins LF, Roach RW, Grunberg SM, et al. Gandara DR, et al. J Clin Oncol. 1993 May;11(5):873-8. doi: 10.1200/JCO.1993.11.5.873. J Clin Oncol. 1993. PMID: 8387576 Clinical Trial.

4

Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancer.

Lau DH, Ryu JK, Gandara DR, Morgan R, Doroshow J, Wilder R, Leigh B. Lau DH, et al. Among authors: gandara dr. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-106-S12-109. Semin Oncol. 1997. PMID: 9331132 Clinical Trial.

5

Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study.

Gandara DR, Edelman MJ, Crowley JJ, Lau DH, Livingston RB. Gandara DR, et al. Cancer Chemother Pharmacol. 1997;41(1):75-8. doi: 10.1007/s002800050710. Cancer Chemother Pharmacol. 1997. PMID: 9443617 Clinical Trial.

6

Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer.

Lau DH, Crowley JJ, Gandara DR, Hazuka MB, Albain KS, Leigh B, Fletcher WS, Lanier KS, Keiser WL, Livingston RB. Lau DH, et al. Among authors: gandara dr. J Clin Oncol. 1998 Sep;16(9):3078-81. doi: 10.1200/JCO.1998.16.9.3078. J Clin Oncol. 1998. PMID: 9738578 Clinical Trial.

7

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically.

Lara PN Jr, Gandara DR, Wurz GT, Lau D, Uhrich M, Turrell C, Raschko J, Edelman MJ, Synold T, Doroshow J, Muggia F, Perez EA, DeGregorio M. Lara PN Jr, et al. Among authors: gandara dr. Cancer Chemother Pharmacol. 1998;42(6):504-8. doi: 10.1007/s002800050852. Cancer Chemother Pharmacol. 1998. PMID: 9788578 Clinical Trial.

8

Concurrent twice-weekly paclitaxel and thoracic irradiation for stage III non-small cell lung cancer.

Lau D, Ryu J, Gandara D, Morgan R, Doroshow J, Wilder R, Leigh B. Lau D, et al. Semin Radiat Oncol. 1999 Apr;9(2 Suppl 1):117-20. Semin Radiat Oncol. 1999. PMID: 10210550 Clinical Trial.

9

Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndrome.

Edelman MJ, Gandara DR, Meyers FJ, Ishii R, O'Mahony M, Uhrich M, Lauder I, Houston J, Gietzen DW. Edelman MJ, et al. Among authors: gandara dr. Cancer. 1999 Aug 15;86(4):684-8. Cancer. 1999. PMID: 10440697 Clinical Trial.

10

RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma.

Mack PC, Gandara DR, Bowen C, Edelman MJ, Paglieroni T, Schnier JB, Gelmann EP, Gumerlock PH. Mack PC, et al. Among authors: gandara dr. Clin Cancer Res. 1999 Sep;5(9):2596-604. Clin Cancer Res. 1999. PMID: 10499638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

445 results

Search Page